Vanda Pharmaceuticals
VNDA
$4.62
Share price
3.12%
Change (1 day)
-24.76%
Change (1 year)
Categories
Vanda Pharmaceuticals (VNDA) - Cash on Hand
Cash on Hand as of December 2023 : $0.38 B
According to Vanda Pharmaceuticals's latest financial reports the company has $0.38 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Vanda Pharmaceuticals - Cash on Hand chart (from 2005 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.38 B | -16.83% |
| 2022-12-31 | $0.46 B | 7.87% |
| 2021-12-31 | $0.43 B | 17.7% |
| 2020-12-31 | $0.36 B | 17.82% |
| 2019-12-31 | $0.31 B | 21.28% |
| 2018-12-31 | $0.25 B | 79.45% |
| 2017-12-31 | $0.14 B | 1.47% |
| 2016-12-31 | $0.14 B | -1.29% |
| 2015-12-31 | $0.14 B | 10.29% |
| 2014-12-31 | $0.12 B | -0.41% |
| 2013-12-31 | $0.13 B | 8.26% |
| 2012-12-31 | $0.12 B | -19.13% |
| 2011-12-31 | $0.14 B | -24.82% |
| 2010-12-31 | $0.19 B | -3.54% |
| 2009-12-31 | $0.20 B | 341.89% |
| 2008-12-31 | $46.45 M | -45.45% |
| 2007-12-31 | $85.17 M | 167.25% |
| 2006-12-31 | $31.87 M | 2.3% |
| 2005-12-31 | $31.15 M | 91.6% |
| 2004-12-31 | $16.25 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $22.92 B | 5,805.00% | 🇺🇸 USA |
 Novartis NVS | $9.69 B | 2,396.75% | 🇨🇭 Switzerland |
 Pfizer PFE | $12.69 B | 3,168.39% | 🇺🇸 USA |
 Eli Lilly LLY | $2.92 B | 654.05% | 🇺🇸 USA |
 Merck MRK | $7.09 B | 1,726.85% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $9.67 B | 2,390.57% | 🇺🇸 USA |
 Titan Pharmaceuticals
TTNP | $6.76 M | -98.26% | 🇺🇸 USA |